CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma.
CLEC10A is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in lung adenocarcinoma.
复制标题
CLEC10A 是一种预后生物标志物,与肺腺癌的临床病理特征和免疫浸润相关
DOI:
10.1111/jcmm.16416
复制
发表时间:
2021-04
影响因子:
5.3
通讯作者:
Zeng S
中科院分区:
文献类型:
--
作者:
He M;Han Y;Cai C;Liu P;Chen Y;Shen H;Xu X;Zeng S
CLEC10A, (C‐type lectin domain family 10, member A), as the member of C‐type lectin receptors (CLRs), plays a vital role in modulating innate immunity and adaptive immunity and has shown great potential as an immunotherapy target for cancers. However, there is no functional research of CLEC10A in prognostic risk, immunotherapy or any other treatment of lung adenocarcinoma (LUAD). We performed bioinformatics analysis on LUAD data downloaded from TCGA (The Cancer Genome Atlas) and GEO (Gene Expression Omnibus), and jointly analysed with online databases such as HPA, LinkedOmics, TIMER, ESTIMATE and TISIDB. We found that lower expression of CLEC10A was accompanied with worse outcomes of LUAD patients. Moreover, CLEC10A expression was significantly correlated with a variety of the tumour‐infiltrating immune cells (TIICs). As a promising prognosis predictor and potential immunotherapy target, the potential influence and mechanisms of CLEC10A in LUAD deserve further exploring.
登录
查看更多内容
DOI:
10.1038/nri2569
发表时间:
2009-07
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
Geijtenbeek TB;Gringhuis SI
通讯作者:
Gringhuis SI
影响因子:
82.9
作者:
通讯作者:
--
影响因子:
32.4
作者:
Saijo, Shinobu;Ikeda, Satoshi;Iwakura, Yoichiro
通讯作者:
Iwakura, Yoichiro
影响因子:
5.6
作者:
Coombs PJ;Harrison R;Pemberton S;Quintero-Martinez A;Parry S;Haslam SM;Dell A;Taylor ME;Drickamer K
通讯作者:
Drickamer K
影响因子:
2.7
作者:
Modak, S;Koehne, G;Cheung, NKV
通讯作者:
Cheung, NKV